July 25, 2014 11:52 PM ET

Capital Markets

Company Overview of Capital International, Inc.

Company Overview

Capital International, Inc. is a privately owned investment manager. The firm primarily provides its services to individuals, corporate and public pension plans and profit sharing plans, pooled investment vehicles, foreign governmental entities, investment companies, corporations, state or municipal government entities, and institutions in Asia, Australia, and New Zealand. It manages client specific portfolios and investment funds for its clients. The firm invests in the public equity, fixed income, and private equity markets across the globe. Its equity investments includes of growth stocks. The firm’s fixed income investments include investment grade securities of governmental, supranation...

11100 Santa Monica Boulevard

15th Floor

Los Angeles, CA 90025-3384

United States

Founded in 1987

Phone:

310-996-6000

Fax:

310-996-6200

Key Executives for Capital International, Inc.

President
Age: 56
Senior Vice President
Managing Partner and Member of Investment Committee
Age: 51
Compensation as of Fiscal Year 2014.

Capital International, Inc. Key Developments

Capital International, Inc. Presents at 16th Annual Global Private Equity Conference, May-13-2014 09:15 AM

Capital International, Inc. Presents at 16th Annual Global Private Equity Conference, May-13-2014 09:15 AM. Venue: Ritz-Carlton, Washington, District Of Columbia, United States. Speakers: Koenraad Carl Alice Foulon, Senior Vice President, Private Equity Senior Managing Partner, Director, and the Chairman of the Investment Committee.

Investors Reportedly Eyes Stake In Intas

Temasek Capital, GIC Pte. Ltd., and Capital International, Inc. are in independent talks to purchase ChrysCapital's 10% stake in Intas Pharmaceuticals Ltd. for about $150 million, three people with direct knowledge of the development said. An investment banker said, "Chrys-Capital is looking to sell part of its 16.5% stake after Intas Pharma postponed its initial public offering due to muted market conditions." "Yes, ChrysCapital is looking for partial exit from the company and the IPO plan was also formulated with the objective of providing exit," Jayesh Shah, Chief Financial Officer of Intas Pharma said in an email response. "However, Intas is still evaluating various options to provide meaningful exit to ChrysCapital and nothing has been concretised so far." Another person familiar with the matter said, "Along with the partial exit of the existing investor, the promoters could look at raising fresh funds for the company." "No valuation number has been frozen," said Shah of Intas.

Balaji Wafers Is In Talks With Investors For 10% Stake Sale

Balaji Wafers Pvt. Ltd. has decided to sell a 10% stake, nearly five months after it began talks with strategic investors to sell a majority stake. Capital International, Inc. and Actis Capital, LLP have emerged as the frontrunners to buy the stake. “We are in talks with these two companies and some others as well,” Balaji Wafers Managing Director Chandubhai Virani said. “We are looking at divesting about a 10% stake and would like to set up new factories with the funds that we raise in the process.” According to Live Mint, J.M. Trivedi, Partner and head of South Asia at Actis, said, “We do not comment on market speculation.” According to Live Mint, an email sent to the media relations team at Capital International on December 6, 2013 did not elicit a response by December 9, 2013. Virani said the promoters were not keen on giving away control of the snacks maker. The exact size of the stake sale could be negotiated, but it would be a minority holding, he said, adding that the process could take another four to six months. The company has mandated consulting fiadrm EY for the transaction. Pepsico, Inc. (NYSE:PEP) is among suitors exploring a bid for Balaji Wafers, Bloomberg reported in August 2013. “The Virani family plans to sell up to a 49% stake for as much as $300 million,” the report said, citing a person familiar with the matter who didn’t want to be named. Balaji Wafers, with revenue of about INR 9 billion in the year ended March 31, 2012, plans to increase sales to INR 15 billion by 2015, Keyur Virani, a director of Balaji Wafers, told Mint in July. The valuation of the brand is about INR 35-40 billion, he claimed.

Similar Private Companies By Industry

Company Name Region
AvantaLion LLC United States
Moseley Holding Corporation United States
Progress Partners, Inc. United States
SJ Levinson & Sons LLC United States
Access Securities, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 26, 2014
Multi Screen Media Pvt. Ltd.
Merger/Acquisition
February 4, 2014
Servicos e Tecnologia de Pagamentos SA
Private Placement
October 10, 2013
Tanner Servicios Financieros S.A.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Capital International, Inc., please visit www.capitalinternational.com.au. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.